Literature DB >> 445362

The cell kinetics of human mammary cancers.

L M Schiffer, P G Braunschweiger, J J Stragand, L Poulakos.   

Abstract

The cellular kinetics of human mammary tumors were studied by in vitro methods. These techniques include single 3HTdR labeling to measure the 3HTdR LI, double labeling with 3HTdR and 14CTdR to measure DNA synthesis time, and an estimation of the growth fraction by the PDP index. Calculations of the potential doubling time and cell cycle time were made from these measurements. The 3HTdR LI of primary malignant tumors was greater than that of benign tumors, but only half that of metastatic lesions. There was considerable heterogeneity in the 3HTdR LI of primary tumors, but the DNA synthesis times were relatively invariant. Estimation of the growth fraction by the PDP index also revealed extensive heterogeneity, but the primary tumors were not different from metastases. There appear to be subsets of tumors with high and low proliferative values that correlate with some clinical parameters, such as age and nodal positivity. This material provides a data base for stratification of patients for future protocols and the use of cell kinetics in treatment programs.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 445362     DOI: 10.1002/1097-0142(197905)43:5<1707::aid-cncr2820430522>3.0.co;2-a

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  10 in total

1.  Mathematical Modeling Links Pregnancy-Associated Changes and Breast Cancer Risk.

Authors:  Daniel Temko; Yu-Kang Cheng; Kornelia Polyak; Franziska Michor
Journal:  Cancer Res       Date:  2017-03-30       Impact factor: 12.701

Review 2.  Surgery plus adjuvant chemotherapy--a review of therapeutic implications. I. Breast cancer.

Authors:  S K Carter
Journal:  Cancer Chemother Pharmacol       Date:  1980       Impact factor: 3.333

3.  Cell kinetics of histologic variants of in situ breast carcinoma.

Authors:  J S Meyer
Journal:  Breast Cancer Res Treat       Date:  1986       Impact factor: 4.872

Review 4.  Cytometry of DNA replication and RNA synthesis: Historical perspective and recent advances based on "click chemistry".

Authors:  Zbigniew Darzynkiewicz; Frank Traganos; Hong Zhao; H Dorota Halicka; Jiangwei Li
Journal:  Cytometry A       Date:  2011-03-18       Impact factor: 4.355

5.  Thymidine labeling index in breast tumors.

Authors:  H D Lee; E Y Soh; H S Chi; B R Kim; K S Lee; K S Song; H J Jung
Journal:  Jpn J Surg       Date:  1990-03

Review 6.  Practical breast carcinoma cell kinetics: review and update.

Authors:  J S Meyer; R W McDivitt; K R Stone; M U Prey; W C Bauer
Journal:  Breast Cancer Res Treat       Date:  1984       Impact factor: 4.872

7.  Inference of tumor evolution during chemotherapy by computational modeling and in situ analysis of genetic and phenotypic cellular diversity.

Authors:  Vanessa Almendro; Yu-Kang Cheng; Amanda Randles; Shalev Itzkovitz; Andriy Marusyk; Elisabet Ametller; Xavier Gonzalez-Farre; Montse Muñoz; Hege G Russnes; Aslaug Helland; Inga H Rye; Anne-Lise Borresen-Dale; Reo Maruyama; Alexander van Oudenaarden; Mitchell Dowsett; Robin L Jones; Jorge Reis-Filho; Pere Gascon; Mithat Gönen; Franziska Michor; Kornelia Polyak
Journal:  Cell Rep       Date:  2014-01-23       Impact factor: 9.423

8.  Short term high density systemic therapy for metastatic breast cancer.

Authors:  D C Tormey; J C Kline; M Palta; T E Davis; R R Love; P P Carbone
Journal:  Breast Cancer Res Treat       Date:  1985       Impact factor: 4.872

9.  Determination of growth fractions in benign breast disease (BBD) with monoclonal antibody Ki-67.

Authors:  R J Lellé; W Heidenreich; G Stauch; I Wecke; J Gerdes
Journal:  J Cancer Res Clin Oncol       Date:  1987       Impact factor: 4.553

10.  The growth law of primary breast cancer as inferred from mammography screening trials data.

Authors:  D Hart; E Shochat; Z Agur
Journal:  Br J Cancer       Date:  1998-08       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.